Get all your news in one place.
100's of premium titles.
One app.
Start reading
Kiplinger
Kiplinger
Business
Dan Burrows

Johnson & Johnson Spins Off Kenvue in Biggest IPO Haul Since 2021

Johnson & Johnson photo shows A bottle of Tylenol sitting next to a box of Tylenol

Johnson & Johnson (JNJ) spun off its Kenvue (KVUE) consumer brands division on Thursday, raising the most cash from an initial public offering (IPO) in more than a year.

Johnson & Johnson said it sold 172.8 million shares at $22 a pop in Kenvue, giving the company whose brands include Band-Aid, Tylenol and Listerine a valuation of roughly $40 billion.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.